2m 2m 2m 2m 2m 2m 2m
COGNITION THERAP (CGTX)
NASDAQ
$0.94+$0.04 (+4.91%)
Price as of Oct 02, 2026 6:08 PM EDT- $84.7MMarket Cap
- -37.68%1-Year Change
- BiotechnologyIndustry
COGNITION THERAP (CGTX)
$0.94+$0.04 (+4.91%)
CGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.89 | ||
Change | -$0.07 (-7.17%) | ||
Open | $0.98 | ||
High | $0.99 | ||
Low | $0.89 | ||
Previous Close | $0.96 | ||
Volume | 792,157 | ||
30-Day Average Volume | 424,015 | ||
1-Week Change | -6.27% | ||
1-Month Change | -11.76% | ||
1-Year Change | -37.68% | ||
3-Year Change | -38.11% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 95.1M | ||
Total Assets | $38.9M | ||
Market Cap | $84.7M | ||
Enterprise Value | $50.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $32.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -22 | ||
PEG | -1 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue